Article
Cross-neutralization activity against SARS-CoV-2 is present in currently available…
medRxiv · 2020 · Diez, J. M.; Romero, C.; Vergara Alert, J.; Bello Perez, M.; Rodon, J.; Honrubia, J. M.; Segales, J.; Sola, I.; Enjuanes, L.; Gajardo, R.
Key facts
| Title | Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins |
|---|---|
| First author | Diez, J. M.; Romero, C.; Vergara Alert, J.; Bello Perez, M.; Rodon, J.; Honrubia, J. M.; Segales, J.; Sola, I.; Enjuanes, L.; Gajardo, R. |
| Journal | medRxiv |
| Published | Aug 16, 2020 |
| DOI | 10.1101/2020.06.19.160879 |
| Devices mentioned | K822496 |
| Product codes mentioned | JIT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1